Sheldon Koenig

Sheldon Koenig

Chief Executive Officer at ESPERION THERAPEUTICS, INC.

Net worth: 2 M $ as of 2026-05-30

60 year
Health Technology
Consumer Services

Profile

Sheldon L.
Koenig
is the founder of Nuvig Therapeutics, Inc. Currently, Mr. Koenig is President, Chief Executive Officer & Director at Esperion Therapeutics, Inc. since 2021.
Formerly, Mr. Koenig was Vice President at Merck & Co., Inc. from 2009 to 2015, Chief Commercial Officer & Executive VP at Portola Pharmaceuticals LLC from 2019 to 2020, and Senior VP & Head-Cardiovascular Franchise at Sanofi Corp.
Education includes an undergraduate degree from Drexel University and an MBA from Monmouth University.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2026-03-30 565,683 ( 0.22% ) 2 M $ 2026-05-30

Sheldon Koenig active positions

CompaniesPositionStart
ESPERION THERAPEUTICS, INC. Chief Executive Officer 2021-05-17

Former positions of Sheldon Koenig

CompaniesPositionEnd
PORTOLA PHARMACEUTICALS, INC. Corporate Officer/Principal 2020-07-31
MERCK & CO., INC. Corporate Officer/Principal 2014-12-31
Founder -
Corporate Officer/Principal -
See the detail of Sheldon Koenig's experience

Training of Sheldon Koenig

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

73

1st degree connections

7

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies7

Health Technology

Health Technology

Health Technology

Consumer Services

Consumer Services

Health Technology

Health Technology

  1. Stock Market
  2. Insiders
  3. Sheldon Koenig
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!